These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 16885366
1. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. Wang Z, Sengupta R, Banerjee S, Li Y, Zhang Y, Rahman KM, Aboukameel A, Mohammad R, Majumdar AP, Abbruzzese JL, Sarkar FH. Cancer Res; 2006 Aug 01; 66(15):7653-60. PubMed ID: 16885366 [Abstract] [Full Text] [Related]
2. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH. Cancer Res; 2006 Mar 01; 66(5):2778-84. PubMed ID: 16510599 [Abstract] [Full Text] [Related]
3. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Zhang Y, Banerjee S, Wang ZW, Marciniak DJ, Majumdar AP, Sarkar FH. Cancer Res; 2005 May 01; 65(9):3877-82. PubMed ID: 15867387 [Abstract] [Full Text] [Related]
4. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. Wang Z, Song W, Aboukameel A, Mohammad M, Wang G, Banerjee S, Kong D, Wang S, Sarkar FH, Mohammad RM. Int J Cancer; 2008 Aug 15; 123(4):958-66. PubMed ID: 18528859 [Abstract] [Full Text] [Related]
5. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Wang Z, Kong D, Banerjee S, Li Y, Adsay NV, Abbruzzese J, Sarkar FH. Cancer Res; 2007 Dec 01; 67(23):11377-85. PubMed ID: 18056465 [Abstract] [Full Text] [Related]
6. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Cancer; 2006 Jun 01; 106(11):2503-13. PubMed ID: 16628653 [Abstract] [Full Text] [Related]
7. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH. Mol Cancer Ther; 2006 Mar 01; 5(3):483-93. PubMed ID: 16546962 [Abstract] [Full Text] [Related]
8. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Zhang Y, Banerjee S, Wang Z, Xu H, Zhang L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, Majumdar AP, Sarkar FH. Cancer Res; 2006 Jan 15; 66(2):1025-32. PubMed ID: 16424038 [Abstract] [Full Text] [Related]
9. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway. Wang Z, Azmi AS, Ahmad A, Banerjee S, Wang S, Sarkar FH, Mohammad RM. Cancer Res; 2009 Apr 01; 69(7):2757-65. PubMed ID: 19318573 [Abstract] [Full Text] [Related]
14. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB. Murtaza I, Adhami VM, Hafeez BB, Saleem M, Mukhtar H. Int J Cancer; 2009 Nov 15; 125(10):2465-73. PubMed ID: 19670328 [Abstract] [Full Text] [Related]
15. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy. Ali S, El-Rayes BF, Sarkar FH, Philip PA. Mol Cancer Ther; 2005 Dec 15; 4(12):1943-51. PubMed ID: 16373709 [Abstract] [Full Text] [Related]
19. EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro. Rishi AK, Parikh R, Wali A, Durko L, Zhang L, Yu Y, Majumdar AP. Anticancer Res; 2006 Apr 15; 26(2A):1029-37. PubMed ID: 16619503 [Abstract] [Full Text] [Related]
20. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, Sarkar FH. Cancer Res; 2006 May 01; 66(9):4816-25. PubMed ID: 16651437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]